NCT07646197Recruiting
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
Impacts of Peanut Intake on Hepatic Markers and Gut Microbiota in Adults With MASLD
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The aim of this randomized interventional trial is to understand the effects of peanut consumption on patients with metabolic associated fatty liver. The main goal is to investigate if patients who consume peanuts have improved liver marker tests as well as metabolic profile. We will also investigate how peanuts alter the gut microbes and liver fat content in patients with metabolic associated fatty liver. * Participants will be randomized into intervention (peanut consumption for 12 weeks) and control (regular diet) arm. * Stool sample and blood (for biomarkers) collection across both arms at baseline and post-intervention * Daily log to be completed for tracking peanut consumption * 2-day Dietary recall at baseline, during Week 6 and Week 12 * Poat intervention Fibro scans for participants with baseline scans available
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- First submitted
- 9 Jun 2026
- Start date
- 9 Jun 2026
- Primary completion date
- 6 Apr 2028
- Lead sponsor
- Henry Ford Health System
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07646197
What you commit to
- Study type: Interventional
- Planned participants: 125
- From 9 Jun 2026 to the primary completion date, 6 Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Food allergy to peanuts or peanut-containing products
- With alcohol use disorder (AUDIT screening)
- Other types of cancer
- Heart or cardiovascular diseases (such as heart attack, stroke, heart failure)
- Kidney diseases (such as chronic kidney disease, kidney transplant, renal insufficiency such as renal failure requiring dialysis)
Other
- Leukemia
- Lymphoma
Who the study is looking for
- 30-70 years
- do not consume peanut/peanut butter/treenut/seeds \> /week
- at least one encounter-related (stage F0/F1) MASLD diagnosis (K76.0)
- Able to understand, speak, and read English
- Mentally competent to consent
Age in the registry: 30 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Henry Ford Health System Coordinator of this site? Confirm its status | Detroit | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.